Can You Give Nitroglycerin with BP 105/68?
Yes, you can administer nitroglycerin to this patient with a blood pressure of 105/68 mmHg, as the systolic pressure is above the 90 mmHg threshold specified in current guidelines, though you should monitor closely for hypotension.
Guideline-Based Blood Pressure Threshold
The 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines explicitly state that sublingual nitroglycerin should be used in hemodynamically stable patients with systolic blood pressure ≥90 mmHg 1. Your patient's systolic pressure of 105 mmHg meets this criterion.
For IV nitroglycerin, the guidelines recommend avoiding use when SBP <90 mmHg or a change in SBP >30 mmHg below baseline 1. The FDA labeling reinforces this, stating nitroglycerin should be used with caution in patients who may be volume-depleted or already hypotensive 2.
Risk Assessment at This Blood Pressure
While your patient meets the minimum threshold, the systolic pressure of 105 mmHg is relatively close to the cutoff, warranting heightened vigilance:
- Expected blood pressure drop: Research shows the mean decrease in systolic BP after sublingual nitroglycerin is approximately 11-15 mmHg 3, 4
- Your patient's margin: With a starting SBP of 105 mmHg and an expected 11-15 mmHg drop, the patient could potentially reach 90-94 mmHg
- Correlation with baseline BP: The magnitude of blood pressure drop is linearly correlated with initial systolic pressure (r = -0.44) 5, meaning lower baseline pressures tend to have smaller absolute drops
Safety Data
Adverse events after prehospital nitroglycerin are rare overall (0.7-3.1%) 4, 3, 5:
- Post-nitroglycerin hypotension (SBP <90 mmHg) occurred in only 3.1% of patients in a large cohort 4
- Serious adverse events (profound bradycardia with hypotension, syncope) occurred in 1.3% of patients 5
- Most adverse events were unpredictable by pretreatment characteristics 5
Research specifically examining patients with SBP >110 mmHg and HR <100 found adverse events were especially rare in this subgroup 4.
Clinical Decision Algorithm
Proceed with nitroglycerin if:
- SBP ≥90 mmHg (✓ your patient qualifies)
- No suspected right ventricular infarction
- No recent PDE5 inhibitor use (within 12-48 hours depending on agent) 1
- Patient not volume depleted
Enhanced monitoring required when:
- SBP 90-110 mmHg (your patient falls here)
- Tachycardia present (HR >100) - increases relative risk of hypotension by 60% 6
- Elderly patients - slightly increased risk 4
Protective measures:
- Have patient sit or lie down before administration 2
- Establish IV access prior to nitroglycerin if possible - associated with fewer adverse events (OR 0.92) 4
- Start with 0.3-0.4 mg sublingual 1
- Recheck blood pressure within 5 minutes after each dose
- Be prepared to place patient in Trendelenburg position and administer IV fluids if hypotension develops
Dosing Protocol
- Initial dose: 0.3 or 0.4 mg sublingual
- Repeat dosing: Every 5 minutes as needed, up to 3 doses total 1
- Hold parameters: If SBP drops below 90 mmHg or patient becomes symptomatic
- Reassess: Blood pressure before each subsequent dose
Critical Contraindications to Rule Out
Before administering, ensure the patient does NOT have:
- Right ventricular infarction (suggested by inferior STEMI with hypotension, elevated JVP, clear lungs) 1
- Recent PDE5 inhibitor use: within 12h of avanafil, 24h of sildenafil/vardenafil, or 48h of tadalafil 1
- Severe aortic stenosis 7
Bottom Line
Your patient's BP of 105/68 mmHg is above the guideline threshold of 90 mmHg systolic, making nitroglycerin administration appropriate. However, the relatively narrow margin requires close monitoring and preparedness to manage potential hypotension. The diastolic pressure of 68 mmHg is not a contraindication - guidelines focus on systolic pressure and mean arterial pressure thresholds.